BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 1 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $86,000 | -12.2% | 1,627 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $98,000 | +6.5% | 1,627 | 0.0% | 0.01% | -14.3% |
| Q1 2020 | $92,000 | +130.0% | 1,627 | +131.4% | 0.01% | +250.0% |
| Q4 2019 | $40,000 | -67.2% | 703 | -69.1% | 0.00% | -75.0% |
| Q3 2019 | $122,000 | -0.8% | 2,274 | +10.0% | 0.01% | -11.1% |
| Q2 2019 | $123,000 | -12.8% | 2,068 | -9.0% | 0.01% | -18.2% |
| Q1 2019 | $141,000 | +2.2% | 2,272 | 0.0% | 0.01% | -8.3% |
| Q4 2018 | $138,000 | +0.7% | 2,272 | -3.1% | 0.01% | +20.0% |
| Q3 2018 | $137,000 | -99.8% | 2,344 | +82.0% | 0.01% | +100.0% |
| Q2 2018 | $57,780,000 | +131218.2% | 1,288 | +30.4% | 0.01% | +25.0% |
| Q1 2018 | $44,000 | +109.5% | 988 | +102.9% | 0.00% | +100.0% |
| Q4 2017 | $21,000 | +425.0% | 487 | +501.2% | 0.00% | – |
| Q3 2017 | $4,000 | 0.0% | 81 | 0.0% | 0.00% | – |
| Q2 2017 | $4,000 | +300.0% | 81 | +376.5% | 0.00% | – |
| Q1 2017 | $1,000 | – | 17 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UBS ASSET MANAGEMENT AMERICAS INC | 2,300 | $203,550,000 | 0.00% |